Aquestive Corp (AQST) - Uzoq muddatli qarzning kapitalga koeffitsiyenti

Aquestive Corp - AQST emitenti grafik logotipi

Aquestive Therapeutics (AQST) polimer plyonkalarni ishlab chiqish uchun ixtisoslashgan kimyogarlarni ishga olmoqda, ushbu qadam GURU.Markets platformasidagi narxlar grafigi tomonidan qo'llab-quvvatlanadi, u asosiy baholash vositasi bo'lib xizmat qiladi va ko'rsatkichni 0.00 darajasida ko'rsatmoqda. Biznes neurologiya sohasidagi himoyaviy talabga tayanadi, bu esa sotuvlarning barqarorligini ta'minlaydi. Shu bilan birga, uning noyob yupqa qatlamli ishlab chiqarish platformasi hajm ortishi bilan xarajatlarni kamaytirish uchun sezilarli imkoniyatlar yaratadi.

Aquestive Therapeutics Inc (AQST): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 31.10.2026gacha

Aquestive Therapeutics (AQST) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya narxi va konsensus maqsadli narx:
Kotirovkalar grafigi Aquestive Therapeutics Inc|AQST - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Aquestive Therapeutics, Inc.|AQST - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Aquestive Therapeutics|AQST - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati aquestive.com|AQST - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Aquestive Therapeutics|AQST - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga nisbati aquestive.com|AQST - Kompaniyaning umumiy qarzi|Qarzning sof aktivlarga nisbati Aquestive Therapeutics, Inc.|AQST - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Aquestive Therapeutics|Oraliq likvidlik koeffitsiyenti aquestive.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
AQST - Sof foyda
Kompaniyaning umumiy tahlili:Aquestive Therapeutics Inc - AQST
Aquestive Therapeutics brend mahsuloti

Investorlar Aquestive Therapeutics (AQST) kompaniyasining barqarorligini moliyaviy leveraj darajasi va qarz mablag'lariga bog'liqlikni aniqlovchi uzoq muddatli qarzdorlikning kapitalga nisbati orqali baholamoqdalar. Kapitalga nisbatan uzoq muddatli qarz tuzilmasini tahlil qilish orqali, Aquestive Therapeutics (AQST) qarz olish xarajatlari ortib borayotgan sharoitda, kritik defolt xatarlarini keltirib chiqarmagan holda, o'z biokimyogarlari faoliyati va uskunalar xaridini qanchalik samarali moliyalashtirayotganini tushunish mumkin.

Raqobatdosh kompaniyalar tahlili

Haleon PLC - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati KVUE|VRNA (Verona Pharma Inc.) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati MENS (Jyong Biotech Ltd)|Uzoq muddatli qarzning kapitalga nisbati ligand.com LGND|AMRX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRGO (Perrigo Company PLC)|Alvotech Corp (ALVO) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Liquidia Inc.|GLPG (Galapagos NV) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati anipharmaceuticals.com|Uzoq muddatli qarzning o'z kapitaliga nisbati MNKD (MannKind)|AMPH (Amphastar Pharmaceuticals Inc) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pacira PCRX|ARS Corp (SPRY) - Uzoq muddatli majburiyatlarning kapitalga nisbati|TBPH: Uzoq muddatli qarzning o'z kapitaliga nisbati|scPharmaceuticals Inc. - Uzoq muddatli kreditlarning kapitalga nisbati|TECX: Uzoq muddatli qarzning kapitalga nisbati|Tonix Pharma - Uzoq muddatli qarzning kapitalga koeffitsiyenti|SXTC (SXT Pharmaceuticals) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Eupraxia Pharma EPRX|Uzoq muddatli qarzning o'z kapitaliga nisbati BioHarvest Sciences (BHST)|EXOZ (invizyne.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati ORMP (Oramed Pharmaceuticals Inc.)|Uzoq muddatli qarzning kapitalga nisbati Entera Bio Ltd ENTX|HYFT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzdorlikning o'z kapitaliga nisbati ABVC BioPharma, Inc (ABVC)|CPIX (Cumberland Pharmaceuticals) - Uzoq muddatli qarzning o'z kapitaliga nisbati|quantumbiopharma.com (QNTM) - Uzoq muddatli qarzning kapitalga nisbati|FGEN (FibroGen) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Telomir Pharmaceuticals Inc TELO|Uzoq muddatli qarzning o'z kapitaliga nisbati Rani Therapeutics (RANI)|Uzoq muddatli qarzdorlikning kapitalga nisbati synergychc.com|Rallybio - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati LEXX (Lexaria Bioscience Corp)|Pulmatrix - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati Pheton Holdings Ltd PTHL|APM (aptorumgroup.com) - Uzoq muddatli qarzning o'z kapitaliga nisbati|LYRA (Lyra Therapeutics Inc) - Uzoq muddatli qarzning o'z kapitaliga nisbati|IBO (Impact BioMedical Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati TNF Pharma TNFA|Uzoq muddatli qarzning o'z kapitaliga nisbati YCBD (cbdMD, Inc.)|PRFX (PainReform Ltd) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Altamira Therapeutics Ltd. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati LIPO (Lipella Pharma)|OptiNose, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti PIRS (pieris.com)|PROC: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Petros Pharmaceuticals Inc (PTPI)|Uzoq muddatli qarzning o'z kapitaliga nisbati Qilian International Holding Group Limited|SLRN: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning kapitalga nisbati TFFP